Transaction

Life Ventures Holding invests in Nawah Scientific for $23 million Series A funding

Announced
18 December 2025
Target
Nawah Scientific Inc.
Value
$23m
Asset class
Venture Capital
Type
Investment, Debt Financing
Instrument
Equity, Debt, Grant
Lead investors
Life Ventures Holding
Investors
Life Ventures Holding, Elsewedy Capital Holding, Angel Investors, M Empire Angels, AfricInvest Capital Partners LLC, Den Venture
Sector
Healthcare / Pharmaceuticals, Biotechnology
Markets
Egypt

About the target

Nawah Scientific Inc., founded in 2015 in Cairo, is a deep-tech life sciences company pioneering the "cloud lab" model across the Middle East and Africa. With primary operational hubs in Cairo and Riyadh, the company provides on-demand analytical and research services to the pharmaceutical, food, and agricultural sectors. Nawah enables remote access to high-end laboratory equipment, offering services such as pharmaceutical formulation, stability studies, and quality control. The company serves over 6,000 clients across 30 countries and has processed over 1 million samples as of 2025. Nawah distinguishes itself through rigorous quality standards, including US FDA approval and ISO 17025, and is the first entity in Africa and the Middle East to achieve ISO 17034 accreditation for certified reference materials. In December 2025, Nawah closed a USD 23 million Series A round led by Life Ventures Holding. This capital is allocated to establish a 10,000-square-metre R&D centre in Rwanda and double laboratory capacity in Egypt and Saudi Arabia.

Sources

  1. www.wamda.com
  2. Partner Researchers